Treating Paralysis vs Paresis
The Management of Peripheral Facial Nerve Palsy: "Paresis" Versus "Paralysis" and Sources of Ambiguity in Study Designs.
Linder TE, Abdelkafy W, Cavero-Vanek S:
Otol Neurotol 2010; 31 (February): [319] [320] [321] [322] [323] [324] [325] [326] [327] In acute facial nerve weakness, paralysis has a worse prognosis and longer recovery period than paresis.
Background:
Several prospective studies have demonstrated the efficacy of steroids in the treatment of acute idiopathic facial nerve paralysis or Bell's palsy. However, few of these studies recognize the distinction between facial paresis and paralysis. Objective: To describe patients presenting with acute peripheral facial paralysis and paresis. Design: Prospective case series. Participants: 176 cases of acute idiopathic and herpes zoster oticus (HZO) facial nerve palsy seen at the outpatient ENT clinic at the University Hospital in Zurich between 1997 and 1999 were included. The protocol also included patients seen between 2002 and 2005 in another tertiary care clinic. Methods: As appropriate, patients had serologic testing, electrophysiologic testing, and imaging studies such as CT or MRI to rule out other causes. Patients with paralysis were tested with electroneuronography (ENoG), which was repeated every 2 to 3 days until a steady state was reached. The published literature on acute facial paralysis between 1976 and 2009 was reviewed. Facial paralysis was graded using the Fisch score. Interventions: Prednisone given at 100 mg daily for 5 to 7 days and valacyclovir 500 mg twice daily for 7 days.
Results: The mean age of the patients was 45 years (range, 12 to 85 years). Bell's palsy was the most frequent diagnosis (157 patients). Of these, 102 had paresis and 55 had paralysis. Of the paresis patients, 41% returned to normal facial nerve function within 1 month, 77% within 2 months, and 88% within 3 months. All except 1 patient recovered completely by 1 year. The paralysis group had a worse prognosis. Seventy percent achieved normal facial nerve function at 1 year, an additional 24% achieved better than a 76 point recovery, and all patients achieved at least some improvement. The complete paralysis group was also examined in terms of ENoG; 73% had denervation <90%, with the remaining patients have near complete denervation. Of those with denervation <90%, 80% had a complete recovery. However, of those with denervation >90%, only 38% had a complete recovery. The herpes zoster oticus group consisted of only 19 patients, which were about evenly split between paralysis and paresis. All except 1 patient with paresis recovered completely within 100 days, and the remaining patient had a Fisch score of 91. Of the paralysis patients only 2 of 9 had a complete recovery at 1 year. The authors reviewed 250 papers over 30 years, but very few recognized the difference between paresis and paralysis and only 3 met the author's inclusion criteria. Conclusions: Those with incomplete facial paralysis tend to recover completely within 3 months. With paralysis, the recovery time is on average twice as long and less favorable. Reviewer's Comments: Should we treat paralysis any different than paresis? This paper does not directly answer this question, but it does raise the issue that for Bell's palsy, one treatment might not be best for all.
(Reviewer-Benjamin T. Crane, MD).
Large Cervicofacial Venous Malformations Remain Treatment Challenge

Diagnosis and Management of Pediatric Cervicofacial Venous Malformations: Retrospective Review From a Vascular Anomalies Center.
Glade RS, Richter GT, et al: The treatment of large cervicofacial venous malformation often requires a combination of surgical excision, laser coagulation, and sclerotherapy.
Background: Venous malformations are congenital low-flow vascular malformations that consist of a collection of aberrant veins that grow with time. They often present in the head and neck area and can cause both functional and cosmetic deformity due to the mass effect.
Objective: This study analyzed a group of patients with cervicofacial venous malformations and derived a treatment algorithm based on the clinical outcomes. Design: A retrospective chart review was done on 19 patients with cervicofacial venous malformations, aged 11 months to 17 years, who were treated at a tertiary referral center over a period from 1996 to 2008. Diagnosis was confirmed with MRI. Patient demographics, as well as treatment records and clinical outcomes, were reviewed. A questionnaire was given to the family to assess subjective outcomes. Results: Presenting complaints included progressive growth (100%), disfigurement (63%), pain (58%), respiratory compromise (42%), and dysphagia (32%). The average age at first intervention was 8.5 years. The number of treatments for each patient ranged from 2 to 12, with a mean of 6.7 treatments per patient. Laser treatments were most commonly used, followed by sclerotherapy and then surgical excision. The average time between treatments was 8.9 months. The complication rate was 3.1%. Subjective satisfaction scores were highest for surgical resection, followed by laser therapy and sclerotherapy.
Conclusions:
The treatment of cervicofacial venous malformation is best achieved with a combination of surgical excision, laser treatments, and sclerotherapy. Multiple treatment sessions are often required for adequate control of symptoms, and complications are usually rare. Reviewer's Comments: Cervicofacial venous malformations are difficult problems that require a multidisciplinary approach depending on the size and location of the lesion. The authors developed a treatment algorithm from their own treatment experience that employed surgical excision and laser therapy as the primary treatment modality for accessible mucosal/skin and deep lesions, respectively. Sclerotherapy is used for less surgically accessible areas and also as a presurgical adjunct treatment. Complete removal of the venous malformation is often neither feasible nor desirable given the size and location. Partial excision is often adequate with the goal of achieving symptom reduction as well as improved cosmesis as the clinical end point.
(Reviewer-Tang Ho, MD).
What Is Best Lower Eyelid Incision to Use in Facial Fx Repair?
The The risk of ectropion is highest with a subciliary incision, while entropion is only seen with a transconjunctival approach.
Background:
The lower eyelid incisions commonly utilized in the exposure and treatment of orbital floor and zygomaticomaxillary complex (ZMC) fractures include the subciliary, subtarsal, and transconjunctival approaches. Each type of incision has its associated advantages and complications. Objective: To review the incidence of lower eyelid malposition associated with various eyelid incisions used to treat craniomaxillofacial fractures at a single institution as well as in the literature. Methods: A retrospective review was made of all facial fractures repaired at an academic medical center requiring lower eyelid incisions from 1998 to 2008. The approaches taken, as well as lower eyelid complications, were analyzed. A meta-analysis was also carried out to examine the rate of lower eyelid complications in facial fracture repair. Results: Among the 180 cases in the study, 41% of the patients were treated with a subtarsal incision, 31% with a subciliary incision, and 25% with a transconjunctival incision. The incidence of ectropion was highest with a subciliary incision (n=7; 12.5%; P =0.018). Two patients with ectropion required surgical correction. Entropion was seen only with the transconjunctival incision (n=2; 4.4%; P =0.108), though both cases of entropion in the study required surgical correction. The meta-analysis included 2,086 patients in 17 studies and showed comparable ectropion risk with a subciliary incision (14%) and entropion risk with a transconjunctival incision (1.5%). The majority of the complications were treated successfully with conservative strategies including eyelid massage and taping.
Conclusions:
The authors favor a subtarsal incision in approaching ZMC fractures and a transconjunctival approach in the treatment of isolated orbital floor fractures given the higher incidence of complications with a subciliary incision. Reviewer's Comments: The best lower eyelid incisional approach depends on individual patient characteristics, and also very important is surgeon's comfort level with the specific approach. Of note in this study, all cases of ectropion (except 1) occurred with 1 of 6 surgeons in the study. As noted by the authors, given the multiple surgeons in the study, the operative details were not uniform. Furthermore, the study is based on a single institution's experience, and its retrospective nature implies all the usual limitations, such as recall and selection bias, apply to this study as well. (Reviewer-Tang Ho, MD).
Anchoring Points in Rhytidectomy --Biomechanical Analysis
Biomechanical Analysis of Anchoring Points in Rhytidectomy. Carron MA, Zoumalan RA, et al: Arch Facial Plast Surg 2010; 12 (January-February): 37-39 Periosteum of the zygomatic root provides the strongest anchoring point for suspension of facial soft tissues.
Objective: To determine the amount of force necessary to cause tissue tear along various anchoring points commonly used in facelift and facial suspension surgeries. Methods: Anatomical study utilizing 4 human cadavers of subjects aged 60 to 70 years for a total of 8 sides. Single 0 Prolene suture was placed through various common anchoring points in facelift. Three regions of the face were tested with 2 anchoring points in each region. Upper face anchoring points included temporalis muscle fascia and periosteum of the zygoma. Midface anchoring points included infralobular tissue and superficial musculoaponeurotic system (SMAS). Lower face anchoring points included the sternocleidomastoid (SCM) fascia and mastoid fascia. Force was applied perpendicular to the face and measured with a digital hanging scale. The amount of force needed to cause suture to tear through the tissue was recorded, averaged, and compared. Results: For the upper face, the periosteum of the zygoma was significantly more durable than the temporalis fascia. Sutures are less likely to tear through tissue if they are placed perpendicular to the grains of the fascia. For the midface, the infralobular tissue was significantly more durable than the SMAS. For the lower face, the mastoid fascia was significantly more durable than the SCM fascia. Conclusions: Tissue tearing force is variable depending on the location of the anchoring points as well as suture orientation in relation to the grain of the fascia. Reviewer's Comments: There is a paucity of quantitative data that exist regarding the relative strength of tissue at various anchoring points for facelift. Although given that this is a cadaver study and the actual tearing force at the anchoring points is unknown, the study does provide useful information in regard to the relative tissue strength at various anchoring points. In clinical practice, it would be important to achieve complete release of tissues and facial ligaments to maximize the results and decrease the overall force placed on the suspension sutures to minimize the risk of sutures tearing through tissues. (Reviewer-Tang Ho, MD).
